SEC INSIDER TRANSACTIONS

VERTEX PHARMACEUTICALS INC / MA (VRTX) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

VRTX · VERTEX PHARMACEUTICALS INC / MA

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-10-27 · 24 filings · fetched 2026-10-27T16:22:24Z

Recent reported activity

0purchase rows on this page

12sale rows on this page

22matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-10-20Filed 2026-10-22	Brennan Daniel J.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. References: F1	A Award / grantCommon Stock · Non-derivative	795A	503.47	Direct	Form 4 ↗0000875320-26-000283
2026-10-15Filed 2026-10-19	Garber Alan MDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. References: F1	A Award / grantDeferred Stock Units · Derivative	29.272A	512.44	Direct	Form 4 ↗0000875320-26-000274
2026-10-15Filed 2026-10-19	SACHS BRUCE IDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. References: F1	A Award / grantDeferred Stock Units · Derivative	92.694A	512.44	Direct	Form 4 ↗0000875320-26-000276
2026-09-08Filed 2026-09-10	van Grunsven JasperOfficer · EVP, CP and NPPO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock unit award that vests in installments beginning on 09/08/2027. References: F1	A Award / grantCommon Stock · Non-derivative	8,682A	0	Direct	Form 4 ↗0000875320-26-000272
2026-08-28Filed 2026-09-01	Ambrose KristenOfficer · SVP & Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock unit award that vests on 03/01/2029. References: F1	A Award / grantCommon Stock · Non-derivative	5,000A	0	Direct	Form 4 ↗0000875320-26-000267
2026-08-27Filed 2026-08-31	SACHS BRUCE IDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	G GiftCommon Stock · Non-derivative	6,000D	0	Direct	Form 4 ↗0000875320-26-000261
2026-07-21Filed 2026-07-23	Tatsis OuraniaOfficer · EVP, Chief Reg. & Quality Off. Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock unit award that vests on 03/31/2030. References: F1	A Award / grantCommon Stock · Non-derivative	8,251A	0	Direct	Form 4 ↗0000875320-26-000253
2026-07-21Filed 2026-07-23	Sachdev AmitOfficer · EVP Chief Patient & Ext Af Off Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock unit award that vests on 03/31/2030. References: F1	A Award / grantCommon Stock · Non-derivative	8,251A	0	Direct	Form 4 ↗0000875320-26-000251
2026-07-15Filed 2026-07-17	SACHS BRUCE IDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. References: F1	A Award / grantDeferred Stock Units · Derivative	99.941A	475.28	Direct	Form 4 ↗0000875320-26-000249
2026-07-15Filed 2026-07-17	Garber Alan MDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. References: F1	A Award / grantDeferred Stock Units · Derivative	31.56A	475.28	Direct	Form 4 ↗0000875320-26-000247
2026-07-02Filed 2026-07-07	Tatsis OuraniaOfficer · EVP, Chief Reg. & Quality Off. Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	1,500D	524.99	Direct	Form 4 ↗0000875320-26-000245
2026-07-02Filed 2026-07-07	McKechnie DuncanOfficer · EVP, Chief Commercial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	1,541D	519	Direct	Form 4 ↗0000875320-26-000243
2026-07-01Filed 2026-07-06	Liu JoyOfficer · EVP and Chief Legal Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	828D	502.71	Direct	Form 4 ↗0000875320-26-000241
2026-06-26Filed 2026-06-30	Bozic CarmenOfficer · EVP and CMO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	596D	482.5	Direct	Form 4 ↗0000875320-26-000239
2026-06-18Filed 2026-06-23	Bozic CarmenOfficer · EVP and CMO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	1,020D	462.17	Direct	Form 4 ↗0000875320-26-000237
2026-06-15Filed 2026-06-17	Bozic CarmenOfficer · EVP and CMO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	4,062D	450	Direct	Form 4 ↗0000875320-26-000235
2026-06-05Filed 2026-06-09	Bozic CarmenOfficer · EVP and CMO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	1,745D	450	Direct	Form 4 ↗0000875320-26-000233
2026-06-01Filed 2026-06-03	Liu JoyOfficer · EVP and Chief Legal Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	828D	439.91	Direct	Form 4 ↗0000875320-26-000230
2026-05-29Filed 2026-06-02	Bozic CarmenOfficer · EVP and CMO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	1,974D	450	Direct	Form 4 ↗0000875320-26-000228
2026-05-15Filed 2026-05-19	Bunnage Mark E.Officer · EVP, Chief Scientific Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	33D	453.45	Direct	Form 4 ↗0000875320-26-000226
2026-05-15Filed 2026-05-19	Bozic CarmenOfficer · EVP and CMO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	1,354D	453.45	Direct	Form 4 ↗0000875320-26-000225
2026-05-12Filed 2026-05-14	Bozic CarmenOfficer · EVP and CMO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	6,988D	450	Direct	Form 4 ↗0000875320-26-000222

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.